@Glitterati
that's my feeling G, I was interested as to why a bunch of current medications that have a mild anti inflammatory effect as a side line have popped up and are seeking consultation with the FDA as to their potential use in the fight against Covid19...
case in point ...Merck ( and to some degree Ivermectin....as per below)
and
( protease inhibitor....mmmm)
side effects include ...
plus a few more but you get the idea... FDA consultation will be interesting for these companies)
so why are they pooping up....
needless to say thanks @Oldpa1 as I suspect it would be off the back of the WHO release in July....it aligns in a lot of respects.
which is fantastic because none of these is peer reviewed for the use against covid and specifically at this stage not recommended for use as a covid treat / exposure prophylaxis ( Quality, safety and efficacy specifically related to this nasty)
It will certainly focus more attention on those companies developing specific anti-inflammatory drug candidates...to wit IHL 675A
exceed our wildest dreams...quite possibly .....like it so far thats for sure
so much to look forward to right now G
GLA
- Forums
- ASX - By Stock
- IHL
- Industry news
Industry news, page-203
-
-
- There are more pages in this discussion • 696 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online